Biological
TG-C
TG-C is a biological therapy with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_2
1
25%
Ph not_applicable
1
25%
Ph phase_3
2
50%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Terminated(1)
Detailed Status
Terminated1
Active, not recruiting1
Not yet recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 3
Trials by Phase
Phase 21 (25.0%)
Phase 32 (50.0%)
N/A1 (25.0%)
Trials by Status
terminated125%
active_not_recruiting125%
not_yet_recruiting125%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
completedphase_3
Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee
NCT03291470
active_not_recruitingphase_3
A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee
NCT03203330
not_yet_recruitingphase_2
A Study to Determine the Safety and Efficacy of TG-C in Subjects with Symptomatic Early Hip Osteoarthritis
NCT05276011
terminatednot_applicable
Tight Glycaemic Control During Cardiac Surgery
NCT01225159
Clinical Trials (4)
Showing 4 of 4 trials
NCT03291470Phase 3
Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee
NCT03203330Phase 3
A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee
NCT05276011Phase 2
A Study to Determine the Safety and Efficacy of TG-C in Subjects with Symptomatic Early Hip Osteoarthritis
NCT01225159Not Applicable
Tight Glycaemic Control During Cardiac Surgery
All 4 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 4